Difference between revisions of "Center for Medicine in the Public Interest"
(→CMPI Advisory Board) |
Tor Justad (talk | contribs) |
||
Line 1: | Line 1: | ||
− | |||
==CMPI Board of Directors== | ==CMPI Board of Directors== | ||
− | The CMPI Board of Directors is comprised of some of the | + | The CMPI Board of Directors is comprised of some of the nation's leaders in academic medical research, clinical practice, health care delivery, patient advocacy, innovation leadership and science reporting. The board will be involved in helping CMPI reaching a broader group of stakeholders in their respective communities and in shaping CMPI programs in the future. |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | + | *[[Bruce Booth]] | |
− | + | :Principal, [[Atlas Venture]] | |
− | + | *[[Bruce Brandfon]] | |
− | + | :Publisher, Scientific American | |
− | + | *[[Fred Goodwin]], M.D. | |
− | + | :Professor of Psychiatry, The George Washington University Medical Center | |
− | Vice | + | *[[Dennis Johnson]] |
− | + | :Vice President, Policy and External Affairs at The [[Children's Health Fund]] | |
− | + | *[[Suzanne Pattee]], J.D. | |
− | + | :Vice president, Public Policy and Patient Affairs for the [[Cystic Fibrosis Foundation]] | |
− | Lecturer, | + | *[[Steven Sammut]] |
− | Wharton School, the Law School and the School of Engineering and Applied Science of the University of Pennsylvania | + | :Lecturer, Wharton School, the Law School and the School of Engineering and Applied Science of the University of Pennsylvania |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | + | *[[Mark Thornton]], M.D., Ph.D. | |
− | + | :Chairman and President, [[Sarcoma Foundation of America]] | |
− | |||
− | + | *[[Michael Weber]], M.D. | |
− | + | :Associate Dean and Professor of Medicine, SUNY Downstate College of Medicine, Brooklyn, New York | |
− | President and CEO, | + | *[[Raymond Woosley]], M.D., Ph.D. |
− | C-Path Institute | + | :President and CEO, [[C-Path Institute]] |
==CMPI Advisory Board== | ==CMPI Advisory Board== | ||
− | Joesph L. Bast | + | *[[Joesph L. Bast]] |
− | President and CEO | + | :President and CEO, The [[Heartland Institute]], Chicago, IL |
− | The Heartland Institute | ||
− | Chicago, IL | ||
− | + | *[[John E. Calfee]] | |
− | John E. Calfee | + | :Senior Fellow, [[American Enterprise Institute]], Washington, D.C. |
− | Senior Fellow | ||
− | American Enterprise Institute | ||
− | Washington, D.C. | ||
− | + | *[[Joseph A. DiMasi]], Ph.D. | |
− | Joseph A. DiMasi, Ph.D. | + | :Director of Economic Analysis, [[Tufts Center for the Study of Drug Development]], Tufts University, Boston, MA |
− | Director of Economic Analysis | ||
− | Tufts Center for the Study of Drug Development | ||
− | Tufts University, Boston, MA | ||
− | + | *[[Helen Disney]] | |
− | [[Helen Disney]] | + | :Director, [[Stockholm Network]], London, England |
− | Director | ||
− | [[Stockholm Network]] | ||
− | London, England | ||
− | + | *[[John Kamp]] | |
− | John Kamp | + | :Executive Director, [[Coalition for Healthcare Communication]] |
− | Executive Director | ||
− | Coalition for Healthcare Communication | ||
− | + | *[[Sam Kazman]] | |
− | Sam Kazman | + | :General Counsel, [[Competitive Enterprise Institute]] |
− | General Counsel | ||
− | Competitive Enterprise Institute | ||
− | + | *Dr. [[Merrill Mathews]], Jr. | |
− | Dr. Merrill Mathews, Jr. | + | :Resident Scholar, [[Institute for Policy Innovation]] |
− | Resident Scholar | + | :Director, [[Council for Affordable Health Insurance]] |
− | Institute for Policy Innovation | ||
− | Director | ||
− | Council for Affordable Health Insurance | ||
− | + | *[[David McIntosh]] | |
− | David McIntosh | + | :Attorney, [[Mayer, Brown, Rowe & Maw]] LLP, Washington, D.C. |
− | Attorney | ||
− | Mayer, Brown, Rowe & Maw LLP | ||
− | Washington, | ||
− | + | *[[Julian Morris]] | |
− | [[Julian Morris]] | + | :Director, [[International Policy Network]], London |
− | Director | ||
− | [[International Policy Network]] | ||
− | + | *[[Tomas J. Philipson]] | |
− | Tomas J. Philipson | + | :Professor, The Harris School, Chicago, IL |
− | Professor | ||
− | The Harris School | ||
− | Chicago, IL | ||
− | + | *[[Stephen Pollard]] | |
− | [[Stephen Pollard]] | + | :Senior Fellow at the [[Centre for the New Europe]], Brussels, Belgium |
− | Senior Fellow at the [[Centre for the New Europe]] | ||
− | Brussels, Belgium | ||
− | + | *[[William Roper]] | |
− | William Roper | + | :CEO, University of North Carolina Health Care System |
− | CEO | ||
− | University of North Carolina Health Care System | ||
− | + | *[[Ellen V. Sigal]], Ph.D. | |
− | [[Ellen V. Sigal]], Ph.D. | + | :Founder and Chairperson, [[Friends of Cancer Research]] |
− | Founder and Chairperson | ||
− | [[Friends of Cancer Research]] | ||
+ | *[[Samuel C. Silverstein]], M.D. | ||
+ | :John C. Dalton Professor and Chairman, Department of Physiology and Cellular Biophysics, Columbia University | ||
+ | :Professor of Medicine, College of Physicians and Surgeons, Columbia University | ||
− | + | *[[Philip Stieg]], M.D. | |
− | + | :Professor and Chairman, Department of Neurological Surgery, Weill Medical College | |
− | and | + | :Neurosurgeon-in-Chief, New York-Presbyterian Hospital |
− | |||
− | |||
− | + | *[[Daniel E. Troy]] | |
− | + | :Former Chief Counsel of the [[Food and Drug Administration]] (FDA) | |
− | + | :Partner in the Washington, New York Offices of [[Sidley Austin Brown & Wood]] | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | Daniel E. Troy | ||
− | Former Chief Counsel of the FDA | ||
− | Partner in the Washington, New York Offices of | ||
− | Sidley Austin Brown | ||
− | + | *[[Grace Marie Turner]] | |
− | [[Grace Marie Turner]] | + | :President, The [[Galen Institute]] |
− | President | ||
− | The Galen Institute | ||
− | + | *[[Ben Zycher]] | |
− | [[Ben Zycher]] | + | :Senior Fellow in Economics, [[Pacific Research Institute]] |
− | Senior Fellow in Economics | + | :Adjunct scholar, [[Cato Institute]], [[Claremont Institute]] |
− | [[Pacific Research Institute]] | ||
− | Adjunct scholar | ||
− | [[Cato Institute]], [[Claremont Institute]] |
Revision as of 18:18, 5 June 2007
CMPI Board of Directors
The CMPI Board of Directors is comprised of some of the nation's leaders in academic medical research, clinical practice, health care delivery, patient advocacy, innovation leadership and science reporting. The board will be involved in helping CMPI reaching a broader group of stakeholders in their respective communities and in shaping CMPI programs in the future.
- Principal, Atlas Venture
- Publisher, Scientific American
- Fred Goodwin, M.D.
- Professor of Psychiatry, The George Washington University Medical Center
- Vice President, Policy and External Affairs at The Children's Health Fund
- Suzanne Pattee, J.D.
- Vice president, Public Policy and Patient Affairs for the Cystic Fibrosis Foundation
- Lecturer, Wharton School, the Law School and the School of Engineering and Applied Science of the University of Pennsylvania
- Mark Thornton, M.D., Ph.D.
- Chairman and President, Sarcoma Foundation of America
- Michael Weber, M.D.
- Associate Dean and Professor of Medicine, SUNY Downstate College of Medicine, Brooklyn, New York
- Raymond Woosley, M.D., Ph.D.
- President and CEO, C-Path Institute
CMPI Advisory Board
- President and CEO, The Heartland Institute, Chicago, IL
- Senior Fellow, American Enterprise Institute, Washington, D.C.
- Joseph A. DiMasi, Ph.D.
- Director of Economic Analysis, Tufts Center for the Study of Drug Development, Tufts University, Boston, MA
- Director, Stockholm Network, London, England
- Executive Director, Coalition for Healthcare Communication
- General Counsel, Competitive Enterprise Institute
- Dr. Merrill Mathews, Jr.
- Resident Scholar, Institute for Policy Innovation
- Director, Council for Affordable Health Insurance
- Attorney, Mayer, Brown, Rowe & Maw LLP, Washington, D.C.
- Director, International Policy Network, London
- Professor, The Harris School, Chicago, IL
- Senior Fellow at the Centre for the New Europe, Brussels, Belgium
- CEO, University of North Carolina Health Care System
- Ellen V. Sigal, Ph.D.
- Founder and Chairperson, Friends of Cancer Research
- Samuel C. Silverstein, M.D.
- John C. Dalton Professor and Chairman, Department of Physiology and Cellular Biophysics, Columbia University
- Professor of Medicine, College of Physicians and Surgeons, Columbia University
- Philip Stieg, M.D.
- Professor and Chairman, Department of Neurological Surgery, Weill Medical College
- Neurosurgeon-in-Chief, New York-Presbyterian Hospital
- Former Chief Counsel of the Food and Drug Administration (FDA)
- Partner in the Washington, New York Offices of Sidley Austin Brown & Wood
- President, The Galen Institute
- Senior Fellow in Economics, Pacific Research Institute
- Adjunct scholar, Cato Institute, Claremont Institute